Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Rebba

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Evaluation in Clinical Practice|September 30, 2010
Taking decisions on expenditure for high-cost drugs at the regional level: a model for evaluating the overall impact of Trastuzumab in the Veneto Region of ItalyAlessandra Buja, Egle Perissinotto, Antonio Compostella, et al.
International Journal of Public Health|September 6, 2021
Opening Schools and Trends in SARS-CoV-2 Transmission in European CountriesAlessandra Buja, Federico Zabeo, Vittorio Cristofori, et al.
International Journal of Environmental Research and Public Health|June 24, 2022
Potential Cost Savings for the Healthcare System by Physical Activity in Different Chronic Diseases: A Pilot Study in the Veneto Region of ItalySara Ortolan, Daniel Neunhaeuserer, Giulia Quinto, et al.
Acta Dermato-Venereologica|November 8, 2017
Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical GuidelinesAlessandra Buja, Gino Sartor, Manuela Scioni, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 16, 2018
Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysisAlessandra Buja, Gino Sartor, Manuela Scioni, et al.
Thoracic Cancer|November 21, 2020
Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease modelAlessandra Buja, Michele Rivera, Anna De Polo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2024
The Cost of Atrial Fibrillation: A Systematic ReviewAlessandra Buja, Vincenzo Rebba, Laura Montecchio, et al.
Health Policy (Amsterdam, Netherlands)|March 1, 2014
Waiting time prioritisation for specialist services in Italy: the homogeneous waiting time groups approachGiuliano Mariotti, Luigi Siciliani, Vincenzo Rebba, et al.
Journal of Medical Screening|November 13, 2019
Cost-effectiveness of a melanoma screening programme using whole disease modellingAlessandra Buja, Michele Rivera, Giovanni Girardi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Evaluation in Clinical Practice|September 30, 2010
Taking decisions on expenditure for high-cost drugs at the regional level: a model for evaluating the overall impact of Trastuzumab in the Veneto Region of ItalyAlessandra Buja, Egle Perissinotto, Antonio Compostella, et al.
International Journal of Public Health|September 6, 2021
Opening Schools and Trends in SARS-CoV-2 Transmission in European CountriesAlessandra Buja, Federico Zabeo, Vittorio Cristofori, et al.
International Journal of Environmental Research and Public Health|June 24, 2022
Potential Cost Savings for the Healthcare System by Physical Activity in Different Chronic Diseases: A Pilot Study in the Veneto Region of ItalySara Ortolan, Daniel Neunhaeuserer, Giulia Quinto, et al.
Acta Dermato-Venereologica|November 8, 2017
Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical GuidelinesAlessandra Buja, Gino Sartor, Manuela Scioni, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 16, 2018
Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysisAlessandra Buja, Gino Sartor, Manuela Scioni, et al.
Thoracic Cancer|November 21, 2020
Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease modelAlessandra Buja, Michele Rivera, Anna De Polo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2024
The Cost of Atrial Fibrillation: A Systematic ReviewAlessandra Buja, Vincenzo Rebba, Laura Montecchio, et al.
Health Policy (Amsterdam, Netherlands)|March 1, 2014
Waiting time prioritisation for specialist services in Italy: the homogeneous waiting time groups approachGiuliano Mariotti, Luigi Siciliani, Vincenzo Rebba, et al.
Journal of Medical Screening|November 13, 2019
Cost-effectiveness of a melanoma screening programme using whole disease modellingAlessandra Buja, Michele Rivera, Giovanni Girardi, et al.
Pageof 2